Login / Signup
Xiao-Yu Hu
ORCID
Publication Activity (10 Years)
Years Active: 2022-2022
Publications (10 Years): 1
Top Topics
Phase Iii
Clinical Trial
Ejection Fraction
Prognostic Factors
Top Venues
Evidence-based complementary and alternative medicine : eCAM
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Yang Zhang
,
Jian-Xing Luo
,
Yan-Ge Li
,
Hong-Fang Fu
,
Fang Yang
,
Xiao-Yu Hu
An Open-Label Exploratory Clinical Trial Evaluating the Effects of GLS (Coptidis Rhizoma-Evodiae Fructus 2 : 1) on Fibroblast Growth Factor 21 in Patients with Nonalcoholic Fatty Liver Disease.
Evidence-based complementary and alternative medicine : eCAM
2022 (2022)